ContractTechnology Rights and Development License Agreement • April 15th, 2016 • Moleculin Biotech, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledApril 15th, 2016 Company Industry JurisdictionThis TECHNOLOGY RIGHTS AND DEVELOPMENT LICENSE Agreement (the “Agreement”) dated as of [month] [date], [year] (the “Effective Date”) is entered into by and between Moleculin Biotech, Inc. (“MBI”), a Delaware corporation, having a business address of 1973 W. Clay St. Houston, TX 77019 and Houston Pharmaceuticals, Inc., (“HPI”), a Texas Corporation, having a business address of 4239 Emory St., Houston, TX 77005. MBI and HPI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”